Home

Articles from restor3d

restor3d Announces First Clinical Cases of the iTotal Identity™ CR 3DP Porous Fully Personalized Total Knee Replacement System
restor3d, a leader in 3D-printed, personalized orthopedic solutions, today announced the successful completion of the first clinical cases using the iTotal Identity™ CR 3DP Porous Fully Personalized Total Knee Replacement System. The inaugural procedure was performed by William J. Berghoff, MD, at Parkview Orthopedic Hospital in Fort Wayne, Indiana, marking a major milestone in the system’s limited market release and the next evolution of personalized knee arthroplasty.
By restor3d · Via Business Wire · December 9, 2025
restor3d Announces Strategic Investment Partnership with Partners Group to Accelerate Growth in Personalized Orthopedic Solutions
restor3d, a leader in technology-driven personalized orthopedic solutions, today announced a strategic investment partnership with Partners Group, one of the largest firms in the global private markets industry, acting on behalf of its clients. Under the agreement, Partners Group will acquire a significant minority stake in restor3d, marking the Company’s first institutional investment.
By restor3d · Via Business Wire · August 22, 2025
restor3d Announces Successful Limited Market Release of the Aeros™ Modular Stem Total Ankle System with Five Cases Performed on Day One
restor3d, a leader in 3D printed, personalized orthopedic implant care, proudly announces the successful limited market release of the Aeros™ Modular Stem Total Ankle System, with five cases performed on launch day, May 5, 2025, at OrthoCarolina by renowned foot and ankle specialists Dr. Kent Ellington and Aeros design team member, Dr. Samuel Ford.
By restor3d · Via Business Wire · May 6, 2025
restor3d Announces FDA Clearance of Ossera™ AFX Ankle Fusion System, Showcasing Innovations at ACFAS 2025
restor3d, a leader in 3D-printed, personalized orthopedic implant care, will showcase its latest foot and ankle innovations at the American College of Foot & Ankle Surgery (ACFAS) Annual Meeting in Phoenix, Ariz., from March 27-30, 2025. Among the highlights is the newly FDA 510(k)-cleared Ossera™ AFX Ankle Fusion System, engineered to advance fusion procedures through cutting-edge 3D printing and TIDAL Technology™.
By restor3d · Via Business Wire · March 27, 2025
restor3d to Debut New Foot & Ankle Offerings at ACFAS Annual Meeting
Attendees at this year’s American College of Foot & Ankle Surgeons (ACFAS) Annual Conference in Tampa, Florida will be the first to see restor3d’s newest Foot & Ankle offerings. The launch includes the patient-specific Total Talus Replacement System and the highly anticipated line extension to the Kinos Axiom® Total Ankle Replacement System, the Kinos X-Stem, Tall featuring a unique Right Angle Drill for controlled stem preparation.
By restor3d · Via Business Wire · January 31, 2024
restor3d Receives FDA Clearance of Patient Specific Resection Guides for use with the Kinos Axiom Total Ankle System
restor3d, a research-driven medical device company, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to the Axiom PSR System for use with the company’s Kinos Axiom Total Ankle System. The Axiom PSR (patient-specific resection) System is additively manufactured from titanium alloy, making it the first all-metal, patient-specific instrument system cleared for use with an ankle arthroplasty system.
By restor3d · Via Business Wire · April 6, 2023
Celebrating Major Milestones in Personalized Orthopaedics, restor3d Announces First Surgery Using the Next Generation Kinos Axiom® Total Ankle System Featuring TIDAL Technology™ and Launches Mobile Companion App of r3id Personalized Surgery Platform
restor3d, a leading medical device company that develops innovative technologies and manufactures 3D printed implants and instruments, celebrates two incredible company milestones. The first being the successful implantation of the next generation Kinos Axiom® Total Ankle System featuring TIDAL Technology™, and the second is today’s launch of the mobile companion App for the r3id Personalized Surgery platform. These releases are the first of many anticipated product launches for restor3d in 2023, and enforce the company’s position of enhancing personalized surgical solutions and digital health.
By restor3d · Via Business Wire · January 23, 2023
restor3d Raises $23 Million to Expand 3D Printed Personalized Solutions for Musculoskeletal Surgery and Develop Machine Learning Enabled Design Tools
restor3d, a leading medical device company and 3D printing manufacturer, has raised $23 million to expand the delivery of 3D printed personalized surgical solutions across multiple musculoskeletal specialties and to develop machine learning software tools for assisting engineers with patient specific implant design.
By restor3d · Via Business Wire · April 5, 2022
Kinos Medical Merges with restor3d
restor3d is pleased to announce an exciting merger with Kinos Medical, a leading total ankle replacement company.
By restor3d · Via Business Wire · May 14, 2021
Articles from restor3d | MarketMinute